Malekghasemi et al., 2020 - Google Patents
Tumor-associated macrophages: Protumoral macrophages in inflammatory tumor microenvironmentMalekghasemi et al., 2020
View HTML- Document ID
- 9003897584975254080
- Author
- Malekghasemi S
- Majidi J
- Baghbanzadeh A
- Abdolalizadeh J
- Baradaran B
- Aghebati-Maleki L
- Publication year
- Publication venue
- Advanced Pharmaceutical Bulletin
External Links
Snippet
Tumor microenvironment consists of malignant and non-malignant cells. The interaction of these dynamic and different cells is responsible for tumor progression at different levels. The non-malignant cells in TME contain cells such as tumor-associated macrophages (TAMs) …
- 210000002540 Macrophages 0 title abstract description 76
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Malekghasemi et al. | Tumor-associated macrophages: Protumoral macrophages in inflammatory tumor microenvironment | |
| Sedighzadeh et al. | A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications | |
| Larionova et al. | Interaction of tumor-associated macrophages and cancer chemotherapy | |
| Pan et al. | Tumor-associated macrophages in tumor immunity | |
| Hinshaw et al. | The tumor microenvironment innately modulates cancer progression | |
| Zhou et al. | Targeting tumor‑associated macrophages in the tumor microenvironment | |
| Grecian et al. | The role of neutrophils in cancer | |
| Wennerberg et al. | Barriers to radiation-induced in situ tumor vaccination | |
| Xiong et al. | CXCL8 in tumor biology and its implications for clinical translation | |
| Saini et al. | Circulating tumor cell-neutrophil tango along the metastatic process | |
| Leone et al. | Targeting adenosine for cancer immunotherapy | |
| Meirow et al. | Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate | |
| Guo et al. | New mechanisms of tumor‐associated macrophages on promoting tumor progression: recent research advances and potential targets for tumor immunotherapy | |
| Yin et al. | Tumor-associated macrophages (TAMs): a critical activator in ovarian cancer metastasis | |
| Millrud et al. | On the origin of myeloid-derived suppressor cells | |
| Peterson et al. | Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages | |
| Yan et al. | Tumor‐associated macrophages in immunotherapy | |
| Galdiero et al. | Tumor associated macrophages and neutrophils in tumor progression | |
| Condamine et al. | Regulation of tumor metastasis by myeloid-derived suppressor cells | |
| Colvin | Tumor-associated macrophages contribute to tumor progression in ovarian cancer | |
| Zhu et al. | Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications | |
| Allavena et al. | Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment | |
| Panni et al. | Targeting tumor-infiltrating macrophages to combat cancer | |
| Mantovani et al. | Pharmacological modulation of monocytes and macrophages | |
| Jäkel et al. | An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells |